Cranial Access (CRAK) Kits, Product / Catalogue No.s: INSHITH, INSHITHND, INSHITHRZN The kits ...

FDA Device Recall #Z-2260-2013 — Class II — September 4, 2013

Recall Summary

Recall Number Z-2260-2013
Classification Class II — Moderate risk
Date Initiated September 4, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Integra LifeSciences Corp. d.b.a. Integra Pain Management
Location Salt Lake City, UT
Product Type Devices
Quantity 8,648

Product Description

Cranial Access (CRAK) Kits, Product / Catalogue No.s: INSHITH, INSHITHND, INSHITHRZN The kits allow for access to the subarachnoid space or the lateral ventricles of the brain. The kits are intended to be used with an external drainage and monitoring system in selected patients to reduce intracranial pressure (ICP), to monitor CSF, to provide temporary drainage of CSF, and to monitor ICP.

Reason for Recall

Integra is recalling certain lots of Cranial Access Kit due to a possibility that the seal integrity of the sterile package may become compromised during shipping.

Distribution Pattern

Nationwide Distribution including CA, CO, FL, IN, KS, NC, NV, NY, OK, TN, TX, VA, WA, and WI.

Lot / Code Information

INSHITH Lots: W1205183,,W1207036,,W1209165,,W1209166,,W1209168,,W1210156,,W1210157,,W1210158,,W1210159,,W1210160,,W1211021,,W1211030,,W1211135,,W1211136,,W1211137,,W1212170 INSHITHND Lots: W1210230 INSHITHRZN Lots: W1209156,,W1211182,,W1212090,,W1212125,,W1212178,,W1301258,,W1302005,,W1302031,,W1303148

Other Recalls from Integra LifeSciences Corp. d.b.a. Int...

Recall # Classification Product Date
Z-2868-2016 Class II PHS Spinal Tray 24G Gertie Marx, Catalogue No. ... Aug 24, 2016
Z-2733-2016 Class II Integra Cranial Access Kits, Catalogue Nos. INS... Aug 24, 2016
Z-2684-2016 Class II INTEGRA Spinal Tray, Catalogue No: 3404875, Con... Aug 4, 2016
Z-0193-2016 Class II Integra¿ Bone Marrow Biopsy Trays Catalogue No.... Sep 22, 2015
Z-2056-2015 Class II Integra¿ Long Epidural Steroid Injection Needle... May 1, 2015

Frequently Asked Questions

Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.